About BFS Molecular
BFS Molecular is a Healthcare company based in Budapest (Hungary) founded in 2017, and was acquired by CareDx in March 2021. The company was acqui-hired. BFS Molecular offers products and services including Molecular Solutions. Its focus areas include Life Sciences, Transplant Medicine and In Vitro Diagnostic Tests.
Company details
Developer of diagnostics for post-transplantation care. The products include StemScan that detects post-transplant chimerism for hematopoietic stem cell transplant, OrganScan that detects donor-derived DNA post-transplant for a solid organ transplant, and Graftrack software for both the products to monitor the result. These diagnostics are based on next-generation sequencing technology.
- Headquarters Budapest, Hungary
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bfsmolecular.com
- Social LinkedIn
- Acquired by CareDx (Mar 2021)
Products & Services of BFS Molecular
BFS Molecular offers a comprehensive portfolio of products and services, including Molecular Solutions.
Provides pioneering molecular innovations for user applications and updates.
Investors in BFS Molecular
BFS Molecular has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CareDx.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Medical solutions for transplant patients are developed and provided. | 1998 | caredx.com | Brisbane, United States |
Investor details for BFS Molecular
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of BFS Molecular
2 dated milestones of BFS Molecular across 4 years, from founding to its latest funding, stage changes and deals.
- Founded BFS Molecular is founded.
- Exit Acquired by CareDx.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Bfs Molecular
Complete news archive for BFS Molecular
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about BFS Molecular
BFS Molecular was founded in 2017.
BFS Molecular is headquartered in Budapest, Hungary.
Developer of diagnostics for post-transplantation care. The products include StemScan that detects post-transplant chimerism for hematopoietic stem cell transplant, OrganScan that detects donor-derived DNA post-transplant for a solid organ transplant, and Graftrack software for both the products to monitor the result. These diagnostics are based on next-generation sequencing technology.
BFS Molecular offers Molecular Solutions.
BFS Molecular has 1 investor. Key investors include CareDx.
Yes. BFS Molecular was acquired by CareDx in March 2021.